[1]
BOONSOM, S., VANNAPRASAHT, S. and PREECHAGOON, Y. 2021. THERAPEUTIC DOSAGE RANGES AND CHRONIC ADVERSE EFFECTS OF TACROLIMUS IN THAI KIDNEY TRANSPLANT PATIENTS. International Journal of Applied Pharmaceutics. 13, 1 (Jan. 2021), 13–16. DOI:https://doi.org/10.22159/ijap.2021.v13s1.Y0053.